{"count": 2, "results": [{"_id": "39257183", "pmid": 39257183, "title": "Diabetes and uterine fibroid diagnosis in midlife: Study of Women's Health Across the Nation (SWAN).", "journal": "J Clin Endocrinol Metab", "authors": ["Mitro SD", "Waetjen LE", "Lee C", "Wise LA", "Zaritsky E", "Harlow SD", "El Khoudary SR", "Santoro N", "Solomon DH", "Thurston RC", "Hedderson MM"], "date": "2024-09-11T00:00:00Z", "doi": "10.1210/clinem/dgae625", "meta_date_publication": "2024 Sep 11", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.562, "text_hl": "Time-varying @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@, @GENE_INS @GENE_3630 @@@insulin@@@, HOMA-IR, and @GENE_SHBG @GENE_6462 @@@SHBG@@@ were not associated with @<m>DISEASE_Leiomyoma</m> @DISEASE_MESH:D007889 @@@fibroid@@@ diagnosis. However, @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ was associated with a 28% lower incidence of @<m>DISEASE_Leiomyoma</m> @DISEASE_MESH:D007889 @@@fibroid@@@ diagnosis (adjusted HR: 0.72, 95% CI: 0.44, 1.17), driven by participants using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (adjusted HR: 0.49, 95% CI: 0.21, 1.12), though precision was limited. ", "citations": {"NLM": "Mitro SD, Waetjen LE, Lee C, Wise LA, Zaritsky E, Harlow SD, El Khoudary SR, Santoro N, Solomon DH, Thurston RC, Hedderson MM. Diabetes and uterine fibroid diagnosis in midlife: Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab. 2024 Sep 11;():. PMID: 39257183", "BibTeX": "@article{39257183, title={Diabetes and uterine fibroid diagnosis in midlife: Study of Women's Health Across the Nation (SWAN).}, author={Mitro SD and Waetjen LE and Lee C and Wise LA and Zaritsky E and Harlow SD and El Khoudary SR and Santoro N and Solomon DH and Thurston RC and Hedderson MM}, journal={J Clin Endocrinol Metab}}"}}, {"_id": "22835064", "pmid": 22835064, "title": "The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.", "journal": "Gynecol Endocrinol", "authors": ["Li B", "Takeda T", "Tsuiji K", "Kondo A", "Kitamura M", "Wong TF", "Yaegashi N"], "date": "2013-01-01T00:00:00Z", "doi": "10.3109/09513590.2012.706668", "meta_date_publication": "2013 Jan", "meta_volume": "29", "meta_issue": "1", "meta_pages": "87-90", "score": 50058.305, "text_hl": "These experimental findings show that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is a potent inhibitor of cell proliferation in @<m>DISEASE_Leiomyoma</m> @DISEASE_MESH:D007889 @@@leiomyoma@@@ cells. ", "citations": {"NLM": "Li B, Takeda T, Tsuiji K, Kondo A, Kitamura M, Wong TF, Yaegashi N. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway. Gynecol Endocrinol. 2013 Jan;29(1):87-90. PMID: 22835064", "BibTeX": "@article{22835064, title={The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.}, author={Li B and Takeda T and Tsuiji K and Kondo A and Kitamura M and Wong TF and Yaegashi N}, journal={Gynecol Endocrinol}, volume={29}, number={1}, pages={87-90}}"}}]}